Instituto de Pesquisa Clínica de Campinas

Campinas, São Paulo 13060-904

2 studies enrolling now · 14 studies all time

What they study most

Acute Myocardial Infarction (AMI), Alzheimer Disease, Atherosclerotic Cardiovascular Disease, COVID-19, Cardiovascular Disease, Cardiovascular Risk, Chronic Kidney Disease, Coronary Revascularization, Coronavirus Disease 2019, Diabetes Mellitus, Type 2, Heart Failure, Inflammation

Studies at this site

• A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity — Recruiting now
• A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1) — Recruiting now
• ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack — Recruiting now
• ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed
• REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels — Running, not enrolling
• A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation — Running, not enrolling
• Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial — Running, not enrolling
• SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes Trial — Completed
• A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes — Completed
• EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction — Running, not enrolling
• Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity — Completed
• Study to Evaluate Safety and Efficacy of Carrimycin for Treatment of Severe Coronavirus Disease 2019 (COVID-19) in Hospitalized Patients — Stopped early
• Dapagliflozin in Respiratory Failure in Patients With COVID-19 — Completed
• Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC) — Completed